Clinical Trials Browser

NCT04018053 2026-01-27

18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy

Phase EARLY_PHASE1 Active not recruiting

16 enrolled 3 charts

Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT04897763 2026-01-07

PERTINENCE

Phase EARLY_PHASE1 Completed

6 enrolled 12 charts

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06645808 2025-12-29

VARTUTRACE

Phase EARLY_PHASE1 Recruiting

32 enrolled

BreastCNSGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Chondrosarcoma, Colonic Neoplasms, Esophageal Neoplasms, Glioblastoma, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Sarcoma, Osteosarcoma, Stomach Neoplasms

NCT04369560 2025-12-17

Virtual Histology of the Bladder Wall for Bladder Cancer Staging

Phase EARLY_PHASE1 Recruiting

42 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT03837821 2025-11-18

CLONEVO

Phase EARLY_PHASE1 Active not recruiting

20 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT01868087 2024-11-01

Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study

Phase EARLY_PHASE1 Completed

30 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT05559177 2022-09-29

An Open, Dose-escalation Clinical Study of Chimeric Exosomal Tumor Vaccines for Recurrent or Metastatic Bladder Cancer

Phase EARLY_PHASE1 Unknown

9 enrolled

Genitourinary

Urinary Bladder Neoplasms, Recurrence

NCT03204266 2022-08-24

Oral Supplementation to Enhance Recovery Pilot Study

Phase EARLY_PHASE1 Completed

46 enrolled

Genitourinary

Urinary Bladder Neoplasms, Urologic Neoplasms

NCT05395260 2022-08-19

FL- 101 Study in Non-Metastatic MIBC

Phase EARLY_PHASE1 Withdrawn

Genitourinary

Urinary Bladder Neoplasms

NCT03266900 2022-04-20

RESECT

Phase EARLY_PHASE1 Terminated

2 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT05180851 2022-02-01

YSCH-01

Phase EARLY_PHASE1 Unknown

28 enrolled

BreastDermatologicGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Virus Diseases

NCT01738815 2021-10-22

Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer

Phase EARLY_PHASE1 Completed

43 enrolled

Genitourinary

Urinary Bladder Neoplasms, Hematuria

NCT05022160 2021-08-26

Preventing Catheter Related Bladder Discomfort (CRBD) With Bilateral Pudendal Nerve Block

Phase EARLY_PHASE1 Unknown

250 enrolled

Genitourinary

Urinary Bladder Neoplasms, Prostatic Neoplasms

NCT02753309 2021-03-19

A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer

Phase EARLY_PHASE1 Completed

33 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT01479348 2020-06-02

Imaging Study for FdCyd and THU Cancer Treatment

Phase EARLY_PHASE1 Terminated

5 enrolled 12 charts

BreastGenitourinaryHead & NeckThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Neoplasms

NCT02646319 2019-06-06

Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations

Phase EARLY_PHASE1 Completed

2 enrolled

BreastGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Recurrence, Uterine Neoplasms, Endometrial Neoplasms

NCT01261299 2018-01-09